Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × atezolizumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 12 Lung Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Small Cell Lung Carcinoma 6 Neoplasms 6 Urinary Bladder Neoplasms 4 Carcinoma, Renal Cell 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Colorectal Neoplasms 3 Solid Tumors 2 Sarcoma, Alveolar Soft Part 2 Ovarian Neoplasms 2 Osteosarcoma 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Small Cell Lung Cancer Extensive Stage 1 Sarcopenia 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Neoplasms 1

Interventions

venetoclax 61 Azacitidine 51 Cytarabine 33 Specimen Handling 28 Biopsy 21 fludarabine 19 Daunorubicin 18 Injections 17 Decitabine 16 fludarabine phosphate 13 Cyclophosphamide 13 Whole-Body Irradiation 12 CPX-351 12 Idarubicin 11 Melphalan 10 Stem Cell Transplantation 9 Busulfan 9 gilteritinib 8 decitabine and cedazuridine drug combination 8 Mycophenolic Acid 8 Granulocyte Colony-Stimulating Factor 8 Magnetic Resonance Spectroscopy 7 Liposomes 7 Filgrastim 7 ivosidenib 6 enasidenib 6 Gemtuzumab 6 revumenib 5 olutasidenib 5 Mesna 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡